Assignee
XINTRUM PHARMACEUTICALS LTD
CN·4 granted patents·8 pending applications·0 citations·filing 2014–2022
Top patents by PatentIndex Score
12 records- 0153US11299548B2Gene combination capable of high-efficiency expression of recombinant human nerve growth factorXINTRUM PHARMACEUTICALS LTD·Filed 2018·Granted Apr 12, 2022·0 cites·6 claims
- 0252US2022298215A1Multi-receptor (GLP-1 receptor, GIP receptor, and Gcg receptor) agonist proteinXINTRUM PHARMACEUTICALS LTD·Filed 2022·Application pending·0 cites
- 0352US2022298214A1Highly effective blood-glucose-lowering protein drugXINTRUM PHARMACEUTICALS LTD·Filed 2022·Application pending·0 cites
- 0451US2021009649A1Intron for increasing expression level of rhngfXINTRUM PHARMACEUTICALS LTD·Filed 2020·Application pending·0 cites
- 0550US2022106371A1Modified recombinant human nerve growth factor and method for preparing the sameXINTRUM PHARMACEUTICALS LTD·Filed 2021·Application pending·0 cites
- 0649US12570767B2Sequences of anti-ecto-5′-nucleotidase antibodiesXINTRUM PHARMACEUTICALS LTD·Filed 2022·Granted Mar 10, 2026·0 cites·3 claims
- 0748US11220525B2Method for dynamically removing recombinant human nerve growth factor precursor by hydrophobic interaction chromatographyXINTRUM PHARMACEUTICALS LTD·Filed 2020·Granted Jan 11, 2022·0 cites·7 claims
- 0848US10443082B2Concentration gradient test reagent kit and testing method for use in bacterial/fungal drug susceptibility testingXINTRUM PHARMACEUTICALS LTD·Filed 2014·Granted Oct 15, 2019·0 cites·12 claims
- 0948US2022105153A1Use of protein-based long-acting preparation in improving sexual dysfunctionXINTRUM PHARMACEUTICALS LTD·Filed 2021·Application pending·0 cites
- 1047US2021002341A1Method for removing n-terminal truncated and abnormal variants in rhngfXINTRUM PHARMACEUTICALS LTD·Filed 2020·Application pending·0 cites
- 1147US2021070821A1Method for preparing highly pure rhngfXINTRUM PHARMACEUTICALS LTD·Filed 2020·Application pending·0 cites
- 1245US2024368299A1Anti-human CD73 monoclonal antibody without hook effectXINTRUM PHARMACEUTICALS LTD·Filed 2022·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →